Hospitals

Amarin Partner EddingPharm Receives Regulatory Approval for VASCEPA® (Icosapent Ethyl) in Mainland China for Cardiovascular Risk Reduction (CVRR)

-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct...

Defence Receives No Objection Letter from Health Canada for Phase I Trial of Its ACCUM-002 (AccuTOX) as an Anti-Cancer Molecule in Patients with Melanoma

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or...

Breast Tissue Expander Market size is set to grow by USD 282.4 million from 2024-2028, Increasing prevalence of breast cancer boost the market, Technavio

NEW YORK, July 4, 2024 /PRNewswire/ -- The global breast tissue expander market size is estimated to grow by USD 282.4 million...

It’s “Red, White & Crew” time! Help Us Celebrate The Great Loop Challenge This Week as Captain Red and His Crew Make Their Final Push Around Florida

ST. PETERSBURG, Fla. and TAMPA, Fla., July 2, 2024 /PRNewswire/ -- As our nation nears the celebration of Independence Day,...

error: Content is protected !!